Exton Michael has filed 8 insider transactions across 1 company since July 2024.
Most recent transaction: a option exercise of 503263 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on February 28, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Exton Michael | Chief Executive Officer | M | Restricted Stock Units | 503263 | $0.00 | 1,006,527.0000 | 365,780,799 | 33.33% | 0.14% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Exton Michael | Chief Executive Officer | M | Common Stock | 503263 | $0.00 | 503,263.0000 | 365,780,799 | 9999.99% | 0.14% |
| Feb. 28, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Exton Michael | Chief Executive Officer | F | Common Stock | 204831 | $1.47 | 298,432.0000 | 365,780,799 | 40.70% | 0.06% |
| Feb. 12, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Exton Michael | Chief Executive Officer | A | Stock Option (Right to Buy) | 1293670 | $0.00 | 1,293,670.0000 | 365,780,799 | 9999.99% | 0.35% |
| Feb. 12, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Exton Michael | Chief Executive Officer | A | Restricted Stock Units | 862440 | $0.00 | 862,440.0000 | 365,780,799 | 9999.99% | 0.24% |
| Feb. 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Exton Michael | Chief Executive Officer | A | Stock Option (Right to Buy) | 2264690 | $0.00 | 2,264,690.0000 | 363,020,303 | 9999.99% | 0.62% |
| Feb. 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Exton Michael | Chief Executive Officer | A | Restricted Stock Units | 1509790 | $0.00 | 1,509,790.0000 | 363,020,303 | 9999.99% | 0.42% |
| July 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Exton Michael | Chief Executive Officer | A | Stock Option (Right to Buy) | 1675000 | $0.00 | 1,675,000.0000 | 0 | 9999.99% | 0.00% |